RNS Number : 6895S
18 March 2021



Acquisition of OSIsoft, LLC (OSIsoft): Update re CFIUS clearance


The Board of AVEVA Group Plc (AVEVA or the Group) provides the following update on the progress of the acquisition of OSIsoft (the Acquisition).


AVEVA has now received all antitrust and regulatory clearances required ahead of completion of the Acquisition, including clearance by the Committee on Foreign Investment in the United States (CFIUS).


The Acquisition is now expected to complete shortly, subject to the delivery of certain customary closing documentation.


AVEVA will provide a further update once the Acquisition has completed.





AVEVA Group plc

Matt Springett (Head of Investor Relations)

Tel: +44 7789 818 684


FTI Consulting LLP

PR Adviser to AVEVA

Edward Bridges

Dwight Burden

Tel: +44 20 3727 1017



Important Notices


This announcement contains statements about AVEVA that are or may be forward looking statements. All statements other than statements of historical facts included in this announcement may be forward looking statements. Without limitation, any statements preceded or followed by or that include the words "targets", "goals", "should", "would", "could", "continue", "plans", "believes", "expects", "aims", "intends", "will", "may", "anticipates", "estimates", "hopes", "projects" or words or terms of similar substance or the negative thereof, are forward looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.